SubscribeSign In
LeaderPortfolio
Billionaire Profile
Marc Rubiralta
Global Rank
#2939

Image: Unsplash Contributor | Unsplash License | via Unsplash

Marc Rubiralta

CEO, Diagnostics
SPAIN
Real-Time Net Worth
$1.294B
Estimated based on Diagnostics stock value as of April 20, 2026
0% (24h)
Age
42
Source
Diagnostics
Industry
Healthcare
Citizenship
SPAIN

Biography

Marc Rubiralta, a Spanish billionaire, is a key figure in the diagnostics industry. As the chair of Werfen, a leading in-vitro diagnostics company, he inherited his stake from his father, who founded the company in 1966. With a current net worth of $1.3 billion, his wealth stems from the healthcare sector, specifically from Werfen. Rubiralta's career has involved strategic acquisitions, including the $2 billion purchase of U.S.-based Immucor. His leadership has been instrumental in Werfen's growth and its role in diagnostics.

Fact Checked
Verified by Editorial Team
Live Data
Updated 4/20/2026

Wealth Over Time

In-Depth Profile

Early Life and Background

Marc Rubiralta is a Spanish billionaire. His father, José María Rubiralta, founded Werfen in 1966 as a distributor of medical supplies. Werfen evolved into a global leader in in-vitro diagnostics.

Rise to Success

Marc Rubiralta, along with his brothers, owns and runs Werfen. He became the chairman of Werfen in 2019. One of his significant strategic moves was the $2 billion acquisition of U.S.-based Immucor. His leadership has contributed to the company's position in the diagnostics market. He also co-owns the Celsa Group, one of Spain's largest industrial groups.

Key Business Strategies

Werfen's growth strategy involved acquiring companies such as Tem and Accriva Diagnostics. Werfen's success is rooted in its ability to produce high-quality diagnostics. Marc Rubiralta has also been involved in expanding the company commercially in the United States and China.

Philanthropy

Information about Marc Rubiralta's specific philanthropic activities could not be found.

Career Milestones

2019

Chairman of Werfen

Appointed Chairman of Werfen, a leading in-vitro diagnostics company.

2019

Acquisition of Immucor

Oversaw the $2 billion acquisition of the U.S.-based Immucor.

Philanthropy & Social Impact

Unknown

Unknown

Undisclosed

Philanthropic activities are not specified.

Business Philosophy & Leadership

Notable Quotes

"Information not found."

Leadership Principles

Focus on Innovation and Quality

Emphasizes the importance of delivering high-quality diagnostic solutions.

Controversies & Challenges

Unknown

Unknown

No information regarding controversies found.

Compare Marc Rubiralta

Net Worth Face-off
Marc Rubiralta vs Elon Musk
Compare Wealth →
Net Worth Face-off
Marc Rubiralta vs Jeff Bezos
Compare Wealth →
Net Worth Face-off
Marc Rubiralta vs Mark Zuckerberg
Compare Wealth →